Ticker Hub
MGNX — AI Analysis & Sentiment
5 recent AI-generated analyses for MGNX. Sentiment and confidence insights updated continuously.
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
MacroGenics' sale of its manufacturing operations for $122.5 million provides crucial non-dilutive funding, reducing cash burn and enabling focused...
May 11, 2026MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
MacroGenics secured $60 million upfront, and up to $20 million in milestones, by selling a capped royalty on ZYNYZ. This provides crucial non-dilut...
May 4, 2026MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
MacroGenics' 2025 financial report, featuring an extended cash runway and reduced operating expenses, provides crucial stability for its pipeline. ...
Mar 9, 2026MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
MacroGenics' extended cash runway into late 2027 significantly de-risks its operations for the near future, offering a crucial lifeline for its pip...
Mar 9, 2026MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
MacroGenics' extension of its cash runway into late 2027 is a significant positive for its near-term viability. This buys time for its clinical pip...
Mar 9, 2026